WEBINAR

Recent federal action to reclassify state-licensed medical marijuana marks a rapidly developing moment for the cannabis industry. In light of this breaking news, you may be wondering, “How does this impact my business? What do I do now?” 
 
While the announcement signals a meaningful shift in federal posture, key details are still evolving – and many stakeholders are already assessing what this could mean for business planning, investment activity, and compliance priorities. 
 
Join us for a 60-minute webinar briefing focused on separating signal from noise: what is currently known, what remains uncertain, and the practical considerations cannabis companies, investors, and ancillary businesses should be watching as the process unfolds. 

In this webinar, we’ll cover: 

• What the reclassification announcement tells us so far – and what it does not 
• Potential implications across regulatory, tax, operational, and investment considerations 
• Near-term risk and opportunity scenarios that may emerge as guidance develops and enforcement priorities evolve 

We hope you’ll join us for this timely conversation as we navigate an industry landscape that is changing in real time.  

SPEAKERS

Adam Korenfield

Partner

CohnReznick

Jamie Reichardt

Partner,

State and Local Tax

Practice Leader

CohnReznick

Seth Sherer

Senior Tax Manager

CohnReznick

"CohnReznick" is the brand name under which CohnReznick LLP and CohnReznick Advisory LLC and their respective subsidiaries provide professional services. CohnReznick LLP and CohnReznick Advisory LLC (and their respective subsidiaries) practice in an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable law, regulations, and professional standards. CohnReznick LLP is a licensed CPA firm that provides attest services to its clients. CohnReznick Advisory LLC provides tax and business consulting services to its clients. CohnReznick Advisory LLC and its subsidiaries are not licensed CPA firms.